Today we relaunch JAMA Express, a pathway in which manuscripts receive expedited review and processing with the goal of online first publication of accepted work within 4 weeks of submission. The JAMA Express pathway includes the standard rigorous editorial and peer review, editing, and production processes, as well as opportunities for amplification of findings with graphics, multimedia, social and news media attention, and the wide international reach of JAMA. JAMA Express is reserved for manuscripts that will be presented as late-breaking research at major scientific meetings or those with time-sensitive findings of major clinical or public health importance. Throughout the pandemic, JAMA has been committed to expedited review and publication of science important for the understanding of SARS-CoV-2 and care of patients with COVID-19. In relaunching JAMA Express for a broader range of science, we acknowledge that prompt communication of novel scientific insights is critical to the efficient delivery of modern health care, to advancing knowledge, and to the translation of evidence to policy and practice. We commit to pursuing this important goal for JAMA authors and readers.
Source: JAMA Online First